Question 1

How quickly can I start treatment if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

Question 2

What support will I receive during the 6 months of treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any specific side effects I should be aware of with Biktarvy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any issues while on the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

Question 6

Can I continue my regular healthcare while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program clinical trial (NCT04650269). Contact the study team or your healthcare provider for specific answers.

What this study is about